Home > Offer to Sell > Pharmaceuticals_and_Biochemicals > Abiraterone

Abiraterone

Inquiry
  Post Date: Nov 13,2014
  Expiry Date: May 12,2015
  Detailed Description: Cas No. :154229-19-3 Abiraterone is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) -- i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens. It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. Cadila Pharmaceuticals has recently started marketing Abiraterone acetate under the trade name Abretone.

  CAS Registry Number:

154229-19-3
  Synonyms: ;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;(3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol;(3b)-17-(3-pyridinyl)-Androsta-5,16-dien-3-ol;
  Molecular Formula: C24H31NO
  Molecular Weight: 349.509
  Molecular Structure: 154229-19-3 Abiraterone

  Company: Chemvon Biotechnology Co., Ltd.     [ China ]          
  Contact: peter
  Tel: +86-21-50790412;86-21-31268550
  Fax: +86-21-50790419
  Email: marketing@chemvon.com,chemvon@hotmail.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.